PCSK9 and hyperlipidemia: In future work, we plan to extend our validation to additional systems, including LDLR−/− mice, PCSK9-induced hyperlipidemia models, diet-induced AS models, and ultimately clinical samples, to further strengthen the robustness and translational relevance of our results.